Vernakalant in oral form is being investigated for the maintenance of normal heart rhythm in patients with atrial fibrillation (AF).
Vernakalant (oral) is being developed in collaboration with Merck.
Global Partner
Vernakalant in oral form is being investigated for the maintenance of normal heart rhythm in patients with atrial fibrillation (AF).
Vernakalant (oral) is being developed in collaboration with Merck.